All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Biosimilars
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Radiopharmaceuticals
    • Science '22 in Review
    • Top Biopharma Trends of 2022
    • Top Med-tech Trends of 2022
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • sign in
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, May 28, 2023
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

Coronavirus microscopic model
Immune

New bivalent exosome vaccine platform may offer potent, broader immunity against SARS-CoV-2

May 8, 2023
No Comments
Multivalent vaccines that could improve SARS-CoV-2 immunity while also preventing infections by other viruses, such as influenza and respiratory syncytial viruses, constitute an urgent public health need. Currently approved vaccines against SARS-CoV-2 are based solely on the spike protein, which provides limited immunity against variations in spike.
Read More
U.S. vaccine illustration

Lawmakers look to future pandemics while COVID-19 challenges remain

May 5, 2023
By Mari Serebrov
No Comments
With the COVID-19 public health emergency ending in the U.S. next week, Congress is looking to use the lessons learned from the pandemic to draft a new iteration of the Pandemic and All-Hazards Preparedness Act to ensure the country is better prepared for the next pandemic.
Read More

Regulatory actions for May 5, 2023

May 5, 2023
No Comments
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Gilead, Optinose, Regeneron, Sanofi, Tonix, Valeo, Vertex, Xortx.
Read More
LSX World Congress 2023

Fewer NMEs, less funding, more M&A: Navigating the industry post-pandemic

May 4, 2023
By Nuala Moran
No Comments
The industry is not over the post-COVID-19 funding crash, and as the dust settles there are mixed signs for future prospects, with some metrics in decline, others more or less back to pre-pandemic levels, and some showing signs of improvement. But on the key productivity metric, there is a downward trend, with fewer new molecular entities (NMEs) approved by both the U.S. FDA and EMA over the last year and a half.
Read More

In the clinic for May 4, 2023

May 4, 2023
No Comments
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Eli Lilly, Eirgenix, Hyundai, Immix, Immunogen, Karyopharm, Pharmaessentia, Transcenta, Vicore.
Read More
Infection

Nanjing Zhihe Pharmaceutical discovers new prodrugs for viral infections

May 4, 2023
No Comments
Nanjing Zhihe Pharmaceutical Technology Co. Ltd. has described nucleotide derivatives acting as prodrugs reported to be useful for the treatment of viral infections.
Read More
Infection

TME Therapeutics patents new PIKfyve inhibitors

May 4, 2023
No Comments
TME Therapeutics LLC has disclosed 1-phosphatidylinositol 3-phosphate 5-kinase...
Read More

In the clinic for May 3, 2023

May 3, 2023
No Comments
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Anaptysbio, Arcutis, Ascletis, Cellenkos, D&D Pharmatech, Horizon, Immatics, Incyte, Mineralys, Moleculin, Okyo, Revive, Scisparc, Scorpion, Silence, Travere.
Read More
Drug capsule and dollar sign

HELP! Sanders fends off mutiny amid bounty of support for US drug pricing bills

May 2, 2023
By Mari Serebrov
No Comments
In its first markup of the 118th Congress May 2, the Senate Health, Education, Labor and Pensions (HELP) Committee, under the new leadership of Sen. Bernie Sanders (I-Vt.), devolved into a brief mutiny of sorts as the committee members started to take up four bipartisan bills aimed at taming prescription drug prices.
Read More

Other news to note for May 2, 2023

May 2, 2023
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alloy, Blackhawk, CBMG, Destiny, Eterna, Exacis, IMV, J&J, Janssen, Lantern, Lundbeck, Medigene, Mindbio, Piramal, Plus, Science 37, Sporegen, Tay, Urogen, Vir, Vyne.
Read More
Previous 1 2 3 4 5 6 7 8 9 … 509 510 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 26, 2023.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for May 26, 2023.
  • FDA approved icons and medical professional

    Genmab, Abbvie to join Roche with FDA nod for CD20 bispecific in lymphoma

    BioWorld
    Five months after the first anti-CD20xCD3 T-cell engaging bispecific antibody, Roche Holding AG’s Lunsumio (mosunetuzumab), cleared U.S. FDA approval for...
  • Illustration of pancreas

    Gene therapy to reverse T2D shows proof of concept at ASGCT

    BioWorld
    The most ambitious objective of any treatment is to eradicate the disease, acting on its origin to cure it instead of treating its symptoms. This is the purpose...
  • PET imaging of RELN-COLBOS (H3447R) carrier brain showing limited aggregation of tau

    Reelin’ in druggable protective pathways with second Alzheimer’s ‘escapee’

    BioWorld
    Investigators have identified a second individual who remained cognitively normal into his late 60s despite having the PSEN1 E280A mutation, which causes a...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing